skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Any feedback on this junior oil and gas company who plan to drill in the Okavango Delta?
Read Answer Asked by Denis on April 28, 2021
Q: TTCF Tattooed Chef Company. Plant-based foods, appear to be growing quickly, good distribution partners, growing product line, looks like cash on the balance sheet to help facilitate growth, vertically integrated.... Too small? Too early? Too much competition in this space? From a high level, do you have an opinion on this one?
Read Answer Asked by Warren on April 28, 2021
Q: Which ETF[s] would you recommend to cover commodities e.g. cereals, minerals, etc?
Read Answer Asked by steve on April 28, 2021
Q: I need a bit of assistance knowing what to do with bond ETFs. With interest rates projected to change in Canada and mounting inflationary pressures in the US, would you go long (as per a G/M article today 'A contrarian case for bonds - and stellar returns ahead' which suggested the CND ETF XLB) or short term (eg VSB, CBO as in an answer you provided today)? In the past I have opted for aggregate bond ETFs feeling interest rate calls were beyond my abilities to 'call the market'.

Thanks for your valued input.
Read Answer Asked by David C. on April 28, 2021
Q: It’s been a while since anyone inquired about AUN, the silver miner. I’m also interested in copper plays that haven’t yet had a run. Fabrice Taylor appeared on BNN a few years ago and described KTR as a potential “lottery ticket”.

What do you make of these two companies and their prospects? Is it advisable to take a position and be patient? Thanks very much.
Read Answer Asked by Brian on April 28, 2021
Q: ABBV is mentioned and recommended frequently in the 5I questions. I have heard that Humira is its strongest asset; is that the case? A BNN guest the other day referred to Humira coming off patent in 2023; does this affect its long term prospects? The company has a very healthy dividend, especially for a US entity; is this sustainable in the long term? Any other comments about ABBV? Thank you for your excellent service.
Read Answer Asked by Leonard on April 28, 2021